MedTrace Logo

Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI

NCT05069350 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-09-13

No results posted yet for this study

Summary

comparing two local anaesthetic agents, Bupivacaine 0.5% versus Oxybuprocaine used topically to provide surface anaesthesia before IVI procedures.

Conditions

  • Pain, Acute

Interventions

DRUG

bupivacaine 0.5% and oxubuprocaine

using each drug as surface anesthesia before intravitreal injections

Sponsors & Collaborators

  • Research Institute of Ophthalmology, Egypt

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-08-01
Completion
2022-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05069350 on ClinicalTrials.gov